BNP Paribas Financial Markets’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.4M | Sell |
114,185
-123,030
| -52% | -$15.5M | 0.01% | 909 |
|
|
2025
Q1 | $26.2M | Sell |
237,215
-52,625
| -18% | -$5.82M | 0.02% | 670 |
|
|
2024
Q4 | $39.6M | Sell |
289,840
-243,484
| -46% | -$33.2M | 0.02% | 531 |
|
|
2024
Q3 | $61.4M | Buy |
533,324
+102,715
| +24% | +$11.8M | 0.04% | 328 |
|
|
2024
Q2 | $59.3M | Sell |
430,609
-1,373
| -0.3% | -$189K | 0.05% | 292 |
|
|
2024
Q1 | $59.6M | Buy |
431,982
+124,352
| +40% | +$17.2M | 0.05% | 288 |
|
|
2023
Q4 | $40.5M | Buy |
307,630
+29,889
| +11% | +$3.94M | 0.05% | 290 |
|
|
2023
Q3 | $31.2M | Buy |
277,741
+57,260
| +26% | +$6.44M | 0.04% | 287 |
|
|
2023
Q2 | $20.8M | Sell |
220,481
-21,201
| -9% | -$2M | 0.03% | 429 |
|
|
2023
Q1 | $24.5M | Buy |
241,682
+43,143
| +22% | +$4.37M | 0.03% | 351 |
|
|
2022
Q4 | $23.7M | Buy |
198,539
+68,480
| +53% | +$8.18M | 0.04% | 387 |
|
|
2022
Q3 | $13.8M | Buy |
130,059
+64,179
| +97% | +$6.82M | 0.02% | 547 |
|
|
2022
Q2 | $6.42M | Buy |
65,880
+15,254
| +30% | +$1.49M | 0.01% | 794 |
|
|
2022
Q1 | $4.75M | Sell |
50,626
-260,316
| -84% | -$24.4M | 0.01% | 964 |
|
|
2021
Q4 | $26.5M | Buy |
310,942
+20,406
| +7% | +$1.74M | 0.04% | 333 |
|
|
2021
Q3 | $27.9M | Sell |
290,536
-1,436
| -0.5% | -$138K | 0.04% | 298 |
|
|
2021
Q2 | $28.4M | Buy |
291,972
+153,176
| +110% | +$14.9M | 0.04% | 338 |
|
|
2021
Q1 | $13.5M | Buy |
138,796
+82,172
| +145% | +$7.99M | 0.02% | 498 |
|
|
2020
Q4 | $5.43M | Buy |
56,624
+21,067
| +59% | +$2.02M | 0.01% | 734 |
|
|
2020
Q3 | $3.42M | Sell |
35,557
-25,923
| -42% | -$2.49M | ﹤0.01% | 904 |
|
|
2020
Q2 | $7.5M | Buy |
61,480
+15,715
| +34% | +$1.92M | 0.01% | 596 |
|
|
2020
Q1 | $3.96M | Sell |
45,765
-2,862
| -6% | -$248K | 0.01% | 783 |
|
|
2019
Q4 | $5.23M | Buy |
48,627
+37,884
| +353% | +$4.07M | 0.01% | 786 |
|
|
2019
Q3 | $968K | Buy |
10,743
+706
| +7% | +$63.6K | ﹤0.01% | 1334 |
|
|
2019
Q2 | $847K | Sell |
10,037
-22
| -0.2% | -$1.86K | ﹤0.01% | 1265 |
|
|
2019
Q1 | $886K | Sell |
10,059
-9,549
| -49% | -$841K | ﹤0.01% | 1288 |
|
|
2018
Q4 | $1.4M | Buy |
19,608
+10,073
| +106% | +$719K | ﹤0.01% | 959 |
|
|
2018
Q3 | $1.17M | Sell |
9,535
-1,181
| -11% | -$145K | ﹤0.01% | 1182 |
|
|
2018
Q2 | $1.05M | Sell |
10,716
-15,194
| -59% | -$1.49M | ﹤0.01% | 1202 |
|
|
2018
Q1 | $2.15M | Sell |
25,910
-32,074
| -55% | -$2.66M | ﹤0.01% | 949 |
|
|
2017
Q4 | $4.5M | Sell |
57,984
-33,489
| -37% | -$2.6M | 0.01% | 680 |
|
|
2017
Q3 | $5.61M | Buy |
91,473
+19,103
| +26% | +$1.17M | 0.01% | 717 |
|
|
2017
Q2 | $3.33M | Buy |
72,370
+57,705
| +393% | +$2.65M | 0.01% | 869 |
|
|
2017
Q1 | $635K | Buy |
14,665
+1,890
| +15% | +$81.8K | ﹤0.01% | 1382 |
|
|
2016
Q4 | $494K | Sell |
12,775
-1,697
| -12% | -$65.7K | ﹤0.01% | 1446 |
|
|
2016
Q3 | $733K | Buy |
14,472
+1,736
| +14% | +$87.9K | ﹤0.01% | 1032 |
|
|
2016
Q2 | $579K | Buy |
12,736
+583
| +5% | +$26.5K | ﹤0.01% | 1445 |
|
|
2016
Q1 | $481K | Sell |
12,153
-4,877
| -29% | -$193K | ﹤0.01% | 1211 |
|
|
2015
Q4 | $963K | Sell |
17,030
-429
| -2% | -$24.3K | ﹤0.01% | 1122 |
|
|
2015
Q3 | $695K | Buy |
17,459
+10,353
| +146% | +$412K | ﹤0.01% | 1202 |
|
|
2015
Q2 | $339K | Buy |
7,106
+5,100
| +254% | +$244K | ﹤0.01% | 1485 |
|
|
2015
Q1 | $79.7K | Buy |
+2,006
| New | +$79.7K | ﹤0.01% | 1793 |
|
|
2014
Q4 | – | Sell |
-4,512
| Closed | -$70.7K | – | 2486 |
|
|
2014
Q3 | $70.7K | Buy |
4,512
+4,349
| +2,668% | +$68.1K | ﹤0.01% | 1999 |
|
|
2014
Q2 | $2.42K | Buy |
163
+133
| +443% | +$1.97K | ﹤0.01% | 2516 |
|
|
2014
Q1 | $421 | Sell |
30
-836
| -97% | -$11.7K | ﹤0.01% | 2629 |
|
|
2013
Q4 | $8.09K | Sell |
866
-17,414
| -95% | -$163K | ﹤0.01% | 2311 |
|
|
2013
Q3 | $207K | Sell |
18,280
-4,713
| -20% | -$53.4K | ﹤0.01% | 1904 |
|
|
2013
Q2 | $308K | Buy |
+22,993
| New | +$308K | ﹤0.01% | 1690 |
|